Evidence map›Paper›PMID 27776518›Full record

ArticleBMC complementary and alternative medicine2016

Evaluation of phytochemicals, antioxidant activity and amelioration of pulmonary fibrosis with Phyllanthus emblica leaves.

Irsa Tahir, Muhammad Rashid Khan, Naseer Ali Shah, Maryam Aftab

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 51 citations in OpenAlex.

  1. Therapeutic potential ofRSC advances · 2025
    Review
  2. Article
  3. Frontiers in pharmacology · 2023
    Review
  4. Antidiabetic and antihyperlipidemic activities ofFood & nutrition research · 2023
    Article
  5. Gold Nanoparticles Prepared withNanomaterials (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Antioxidants ofOxidative medicine and cellular longevity · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Irsa TahirDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan.
Muhammad Rashid KhanDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan. mrkhanqau@yahoo.com.
Naseer Ali ShahDepartment of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan.
Maryam AftabDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, 45320, Pakistan.
Quaid-i-Azam University · PKCOMSATS University Islamabad · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the present study the antioxidant potential of a methanol extract of Phyllanthus emblica leaves (PELE) was determined by in vitro methods as well as by an in vivo animal model, along with HPLC-DAD screening for phyto-constituents.

methodsThe in vitro antioxidant potential of PELE was assessed by scavenging of DPPH, nitric oxide and anti-lipid peroxidation assays. For in vivo evaluation, a 60-day experimental plan was followed in which Sprague Dawley rats were administered with 1 mL/kg of CCl

resultsPELE exhibited an appreciable in vitro antioxidant activity and scavenged the DPPH radical (IC

conclusionThe findings of this study demonstrate that presence of polyphenolics and other active constituents in PELE might play a significant role in repairing the pulmonary damages instigated with CCl

Indexed as

AnimalsAntioxidantsLipid PeroxidationLungMaleOxidative StressPhyllanthus emblicaPlant ExtractsPlant LeavesPulmonary FibrosisRatsRats, Sprague-DawleyAntioxidantsPlant ExtractsAntioxidantHistopathologyHPLCPhyllanthus emblicaPulmonary

Identifiers

PMID27776518
PMCPMC5078946
OpenAlexW2539030426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.